若把中国生物医药产业的崛起比作一部波澜壮阔的史诗,复星医药无疑是其中笔墨浓重的篇章,其战略演进就是一部中国生物医药产业从“仿制药大国”向“创新药强国”转型的缩影简史。从1994年在上海一隅起步,到如今又是创新浪潮的旗手,复星医药每一次转身都始终紧扣时代脉搏。而今,我们又将再一次见证复星医药的华丽转型。加码创新作为老牌Bigpharma,复星医药的“4IN”(创新Innovation、国际化...
Source Link若把中国生物医药产业的崛起比作一部波澜壮阔的史诗,复星医药无疑是其中笔墨浓重的篇章,其战略演进就是一部中国生物医药产业从“仿制药大国”向“创新药强国”转型的缩影简史。从1994年在上海一隅起步,到如今又是创新浪潮的旗手,复星医药每一次转身都始终紧扣时代脉搏。而今,我们又将再一次见证复星医药的华丽转型。加码创新作为老牌Bigpharma,复星医药的“4IN”(创新Innovation、国际化...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.